Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
J Fluoresc ; 32(6): 2189-2198, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36030478

RESUMEN

The construction of a universal nanoplatform for sensitive detection of multiple targets of interest is of great importance in different research fields. Herein, by ingeniously integrating the target recognition sequences and G-rich sequences into a single-stranded multifunctional DNA probe and adopting Ti3C2 nanosheets as an efficient fluorescence quencher, a simple, low-cost and easy operation fluorescence sensing nanoplatform was proposed. Without an analytical target, the hydrogen bond and metal chelate interaction between the target recognition region of the DNA probe and Ti3C2 nanosheet induce the selective self-assembly of highly fluorescent thioflavin T (ThT)-intercalated DNA probe onto the surface of Ti3C2 nanosheets, resulting in dramatic decrease of fluorescence emitted by ThT-G-quadruplex. In the presence of a target, the target recognition region will selectively bind with the target and the constrained DNA probe is released from the Ti3C2 nanosheets surface, leading to enhanced fluorescence recovery of ThT-G-quadruplex. As a proof of concept, the sensitive and selective detection of p53 gene, Hg2+, and adenosine with the assistance of Ti3C2 nanosheets-based fluorescence sensing nanoplatform were successfully realized. Moreover, it is also applicable for the evaluation the level of these analytical targets in real samples. By simply switching the recognition sequences of DNA probe, the universal sensing strategy could also be applied for detecting many other types of targets. The simple and universal sensing nanoplatform is expected to promote wide applications in environment monitoring and bioanalysis.


Asunto(s)
Técnicas Biosensibles , G-Cuádruplex , Mercurio , Fluorescencia , Colorantes Fluorescentes/química , Sondas de ADN , Mercurio/análisis , ADN de Cadena Simple , Adenosina , Técnicas Biosensibles/métodos , Límite de Detección
2.
BMC Genomics ; 21(1): 875, 2020 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-33287707

RESUMEN

BACKGROUND: The electrosensory ampullary organs (AOs) and mechanosensory neuromasts (NMs) found in sturgeon and some other non-neopterygian fish or amphibians are both originated from lateral line placodes. However, these two sensory organs have characteristic morphological and physiological differences. The molecular mechanisms for the specification of AOs and NMs are not clearly understood. RESULTS: We sequenced the transcriptome for neomycin treated sturgeon AOs and NMs in the early regeneration stages, and de novo assembled a sturgeon transcriptome. By comparing the gene expression differences among untreated AOs, NMs and general epithelia (EPs), we located some specific genes for these two sensory organs. In sturgeon lateral line, the voltage-gated calcium channels and voltage-gated potassium channels were predominant calcium and potassium channel subtypes, respectively. And by correlating gene expression with the regeneration process, we predicated several candidate key transcriptional regulation related genes might be involved in AOs and NMs regeneration. CONCLUSIONS: Genes with specific expression in the two lateral line sensory organs suggests their important roles in mechanoreceptor and electroreceptor formation. The candidate transcriptional regulation related genes may be important for mechano- and electro- receptor specification, in a "dosage-related" manner. These results suggested the molecular basis for specification of these two sensory organs in sturgeon.


Asunto(s)
Sistema de la Línea Lateral , Animales , Peces/genética , Mecanorreceptores , Regeneración/genética , Transcriptoma
3.
Anal Chim Acta ; 1136: 72-81, 2020 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-33081951

RESUMEN

The development of sensitive fluorescence sensors and efficient preparation of samples is a challenge in the detection of pesticides in complex samples. In this study, multicolor nitrogen dots (M-Ndots) were synthesised via microwave irradiation at 140 °C for 10 min with 5-amino-1H-tetrazole and p-phenylenediamine as precursors, which have a high fluorescence quantum yield of up to 31%. Furthermore, the M-Ndots were employed as fluorescence sensors for pesticide detection by being combined with a gas membrane separation device, to eliminate the interference from the complex sample matrix. In this process, the M-Ndots were used for sensing thiram and chlorpyrifos through their affinities to Cu2+ and Fe3+, respectively. Because thiram could decompose into volatile CS2, its derivate was sensed using the fluorescence of M-Ndots via a complexation reaction with Cu2+. Chlorpyrifos, due to its volatility, can reduce the Fe3+ ion by inhibiting the activity of acetylcholinesterase, which produces H2O2 to oxidise Fe2+. In a real application, the time consumption for 96 samples was less than 30 min in one run of the gas membrane separation device. The recoveries for thiram and chlorpyrifos ranged from 90.0% to 115.0%, and the analytical results were validated using LC-MS/MS methods, with relative errors ranging from -7.4% to 10.1%.


Asunto(s)
Cloropirifos , Puntos Cuánticos , Cloropirifos/análisis , Cromatografía Liquida , Frutas/química , Peróxido de Hidrógeno , Nitrógeno , Espectrometría de Masas en Tándem , Tiram/análisis , Verduras
4.
Talanta ; 195: 550-557, 2019 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-30625582

RESUMEN

In this work, a strategy of sulfur-rich doped nitrogen dots (S-Ndots) based on a single-source precursor (SSP) was developed and applied to sensing of Hg2+. Fluorescent S-Ndots were synthesized by microwave-assisted method using 2-azidothiazole as a single-source precursor, which served as carbon, nitrogen and sulfur source simultaneously. This SSP approach guarantee efficient core doping and improve the effect of doping in a molecular level, which is more efficient and simpler than the doping strategy with multiple precursors. The results showed that the as-synthesized S-Ndots have high sulfur component up to 24.6%, and their specific structure effectively promoted artificial peroxidase activity and coordination interaction. Interestingly, the fluorescence intensity could be quenched obviously and the peroxidase activity of the S-Ndots were selectively inhibited by Hg2+, then the S-Ndots were applied to the dual-mode sensing of Hg2+ with both fluorometric and colorimetric readout. The S-Ndots-based sensing assay with simplicity and rapidity showed high selectivity to Hg2+ with the detection limit of 0.1 µmol/L by fluorescence spectroscopy and a distinguishable change in the color was observed by the naked eye. In addition, the accuracy and precision were evaluated based on the quantitative detection of Hg2+ in industrial waste water samples with satisfactory results. Moreover, the S-Ndots with good biocompatibility were further explored for imaging of Hg2+ in A549 cells. As a novel member of nitrogen quantum dots family, the S-Ndots hold great promise to broaden its applications in environmental and biological sensing.

5.
J Thorac Dis ; 10(6): 3609-3621, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30069358

RESUMEN

BACKGROUND: Nearly one-third of the population worldwide is estimated to have latent tuberculosis infection (LTBI), which represents a vast reservoir for a constant source of tuberculosis (TB) transmission. It has been suggested that cynomolgus macaques are less susceptible to Mycobacterium tuberculosis (M.tb) infection than rhesus macaques, we examined M.tb infection of Chinese cynomolgus macaques. METHODS: Eight Chinese cynomolgus macaques were infected with M.tb Erdman strain with a small [25 colony forming unit (CFU)] or large dose (500 CFU) via bronchoscopy. The infected animals were monitored for symptoms and examined by chest X-ray, computed tomography (CT), tuberculin skin test (TST), and enzyme-linked immunospot (ELISPOT). RESULTS: Based on TST conversion and the specific immune responses to M.tb antigens, all animals were successfully infected. Half of the animals developed active infection and died within 15 months postinfection. The other four animals were grouped with latent M.tb infection because of positive TST but few clinical signs and pathological changes of TB during the course of this study. Interestingly, a challenge with a large dose of M.tb also induced latent infection. Similar to the changes that occur with human TB patients, the animals with active infection exhibited weight loss, cough and typical TB pathological changes, including caseous granulomas, cavities, consolidation, lipid pneumonia, pleural effusion, lymphadenopathy and bacterial burden in lungs and other organs. CONCLUSIONS: The low dose of M.tb was sufficient to cause both active and latent M.tb infection in cynomolgus macaques of Chinese origin.

6.
Talanta ; 178: 515-521, 2018 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-29136856

RESUMEN

A simple method was developed for the preparation of silver nanoparticles (AgNPs) by using amino-functionalized nitrogen dots (N-dots) as reductant and stabilizer under mild conditions. N-dots were hydrothermal synthesized using 2-azidoimidazole as the precursor in aqueous ammonia. The as prepared N-dots were rich in nitrogen and oxygen-containing functional groups and exhibit strong reducing capacity. Therefore, AgNPs were rapidly synthesized under mild conditions based on N-dots serving as the reducing agent, the reaction time and temperature were 5min and 40°C, respectively. Moreover, owing to the abundant functional groups on the surface of N-dots, the obtained AgNPs/N-dots nanocomposites with the average diameters of 12.9nm were well dispersed and stable at 4°C for at least two months. Furthermore, the synthesized AgNPs/N-dots showed high surface-enhanced Raman scattering (SERS) activity and provided a sensitive SERS sensing ability for malachite green (MG) and crystal violet (CV) in aquaculture water, with the low detection limit (S/N = 3) of 2.7nmol/L and 2.0nmol/L, respectively, corresponding with the wide linear range from 10.0 to 1000.0nmol/L for MG and 5.0-100.0nmol/L for CV. This method offers an easy and low-cost way to prepare AgNPs/N-dots substrates and makes SERS detection more practicable.

7.
Anal Chem ; 89(7): 4238-4245, 2017 04 04.
Artículo en Inglés | MEDLINE | ID: mdl-28266840

RESUMEN

Fluorescent amino nitrogen quantum dots (aN-dots) were synthesized by microwave-assisted method using 2-azidoimidazole and aqueous ammonia. The aN-dots have a nitrogen component up to 40%, which exhibit high fluorescence quantum yield, good photostability, and excellent biocompatibility. We further explored the use of the aN-dots combined with AuNPs as a nanoprobe for detecting fluorescently and imaging of cysteine (Cys) in complex biological samples. In this sensing system, the fluorescence of aN-dots was quenched significantly by gold nanoparticles (AuNPs), while the addition of Cys can lead to the fluorescence signal recovery. Furthermore, we have demonstrated that this strategy can offer a rapid and selective detection of Cys with a good linear relationship in the range of 0.3-3.0 µmol/L. As expected, this assay was successfully applied to the detection of Cys in human serum and plasma samples with recoveries ranging from 90.0% to 106.7%. Especially, the nanoprobe exhibits good cell membrane permeability and excellent biocompatibility by CCK-8 assay, which is favorable for bioimaging applications. Therefore, this fluorescent probe ensemble was further used for imaging of Cys in living cells, which suggests our proposed method has strong potential for clinical diagnosis. As a novel member of the quantum-dot family, the aN-dots hold great promise to broaden applications in biological systems.


Asunto(s)
Adenocarcinoma del Pulmón/sangre , Cisteína/sangre , Colorantes Fluorescentes/química , Neoplasias Pulmonares/sangre , Nanopartículas/química , Nitrógeno/química , Puntos Cuánticos/química , Adenocarcinoma del Pulmón/patología , Técnicas Biosensibles , Línea Celular Tumoral , Supervivencia Celular , Colorantes Fluorescentes/síntesis química , Humanos , Neoplasias Pulmonares/patología , Tamaño de la Partícula , Espectrometría de Fluorescencia , Propiedades de Superficie
8.
Front Microbiol ; 7: 2174, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-28133458

RESUMEN

Tuberculosis (TB) is a common opportunistic infection and the leading cause of death for human immunodeficiency virus (HIV)-infected patients. Thus, it is necessary to understand the pathogenetic interactions between M.tb and HIV infection. In this study, we examined M.tb and/or simian immunodeficiency virus (SIV) infection of Chinese rhesus macaques. While there was little evidence that M.tb enhanced SIV infection of macaques, SIV could facilitate M.tb infection as demonstrated by X-rays, pathological and microbiological findings. Chest X-rays showed that co-infected animals had disseminated lesions in both left and right lungs, while M.tb mono-infected animals displayed the lesions only in right lungs. Necropsy of co-infected animals revealed a disseminated M.tb infection not only in the lungs but also in the extrapulmonary organs including spleen, pancreas, liver, kidney, and heart. The bacterial counts in the lungs, the bronchial lymph nodes, and the extrapulmonary organs of co-infected animals were significantly higher than those of M.tb mono-infected animals. The mechanistic studies demonstrated that two of three co-infected animals had lower levels of M.tb specific IFN-γ and IL-22 in PBMCs than M.tb mono-infected animals. These findings suggest that Chinese rhesus macaque is a suitable and alternative non-human primate model for SIV/M.tb coinfection studies. The impairment of the specific anti-TB immunity is likely to be a contributor of SIV-mediated enhancement M.tb infection.

9.
Asian Pac J Cancer Prev ; 15(20): 8923-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25374230

RESUMEN

BACKGROUND: Increasing evidence suggests that stromal monocarboxylate transporter 4 (MCT4) and carbonic anhydrase IX (CA IX) may play key roles in tumor development. However, their clinical value remains largely unexplored in gastric cancer (GC). The present study aimed to determine clinicopathological significance and prognostic values of stromal MCT4 and CA IX in GC. MATERIALS AND METHODS: Specimens from 143 GC patients were immunohistochemically stained using polyclonal anti-MCT4 and anti-CA IX antibodies. Expression was correlated with patient clinicopathologic characteristics and survival data. RESULTS: High stromal MCT4 expression was detected in 72 of 143 (50.3%) GCs and high CA IX in 74 (51.7%). Both high stromal MCT4 and CA IX were correlated with advanced TNM stage (p=0.000; p=0.000). High CA IX expression was positively related to depth of invasion (p=0.022) and positive lymph nodes (p=0.002) as well. Survival analysis indicated high expression of stromal MCT4 to be an independent factor in predicting poor overall survival (OS) (HR and 95%CI=1.962, 1.032-3.729, p=0.040) and disease free survival (DFS) (HR and 95%CI=2.081, 1.158-3.741, p=0.014) of GC patients. However, high CA IX expression exhibited no significant predictive value. CONCLUSIONS: These findings suggest that high expression of stromal MCT4 and CA IX proteins is significantly correlated with GC progression. High stromal MCT4 heralds worse outcome of GC patient, suggesting a novel candidate prognostic marker and therapeutic target.


Asunto(s)
Adenocarcinoma Mucinoso/mortalidad , Adenocarcinoma/mortalidad , Antígenos de Neoplasias/metabolismo , Biomarcadores de Tumor/metabolismo , Anhidrasas Carbónicas/metabolismo , Transportadores de Ácidos Monocarboxílicos/metabolismo , Proteínas Musculares/metabolismo , Neoplasias Gástricas/mortalidad , Células del Estroma/metabolismo , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Adenocarcinoma Mucinoso/metabolismo , Adenocarcinoma Mucinoso/patología , Adulto , Anciano , Anciano de 80 o más Años , Anhidrasa Carbónica IX , Femenino , Estudios de Seguimiento , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Estadificación de Neoplasias , Pronóstico , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patología , Células del Estroma/patología , Tasa de Supervivencia , Adulto Joven
10.
Int J Infect Dis ; 16(11): e816-25, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22921259

RESUMEN

OBJECTIVES: To evaluate regimens using bacillus Calmette-Guérin (BCG) or recombinant BCG (rBCG) overexpressing Ag85B for priming, followed by boosting with a modified vaccinia virus Ankara strain (MVA) and/or adenovirus vector (AD) expressing an Ag85B-ESAT6 fusion protein. METHODS: Cellular and humoral immune responses were determined after subcutaneous vaccination, which was employed to trigger systemic immunity against intravenous infection in a mouse model of tuberculosis (TB). Bacterial loads and lung histology were evaluated. RESULTS: The relative IgG2a and IgG1 antibody levels indicated that the viral-vectored vaccines generated a T-helper type 1 (Th1)-biased response after two doses of viral boost vaccinations. Boosting BCG-primed mice with viral vaccines induced a Th1 immune response that included both CD4 and CD8 T-cells generating antigen-specific interferon-gamma (IFN-γ) and CD8 T cytotoxic activity. Only mice vaccinated with two different viral boosters after BCG priming exhibited a significant reduction in bacterial burden in the lung after challenge. Histology examinations confirmed the attenuation of lung damage and more compact granulomas. After mycobacteria priming, boosting with AD85B-E6 followed by MVA85B-E6 afforded better protection than the reverse order of administration of the viral vectors. CONCLUSIONS: This study demonstrates the potential of multiple heterologous viral booster vaccines, although the exact correlates of protection and optimal regimens should be further investigated for the rational design of future vaccine strategies.


Asunto(s)
Vacuna BCG/farmacología , Vectores Genéticos/inmunología , Mycobacterium tuberculosis/inmunología , Tuberculosis/inmunología , Tuberculosis/prevención & control , Animales , Anticuerpos Antibacterianos/sangre , Vacuna BCG/genética , Vacuna BCG/inmunología , Pruebas Inmunológicas de Citotoxicidad , Femenino , Histocitoquímica , Interferón gamma/sangre , Ratones , Ratones Endogámicos BALB C , Mycobacterium tuberculosis/genética , Organismos Libres de Patógenos Específicos , Células TH1/inmunología , Tuberculosis/microbiología , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunología , Vacunas Sintéticas/farmacología
11.
Chin Med J (Engl) ; 125(3): 491-5, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22490409

RESUMEN

BACKGROUND: Azithromycin can reduce neutrophil accumulation in neutrophilic pulmonary diseases. However, the precise mechanism behind this action remains unknown. Our experiment assessed whether azithromycin inhibits neutrophil accumulation in the airways by affecting interleukin-17 (IL-17) downstream signals. METHODS: Mice were pretreated with azithromycin before murine IL-17A (mIL-17) stimulation. After the mIL-17 stimulation, the levels of six neutrophil-mobilizing cytokines were determined by enzyme-linked immunosorbent assay (ELISA) tests in bronchoalveolar lavage (BAL) fluid; IL-6, CXC chemokine ligand-1 (CXCL-1), CXCL-5, macrophage inflammatory protein-2 (MIP-2), granulocyte colony-stimulating factor (G-CSF), and granulocyte macrophage colony-stimulating factor (GM-CSF). The number of neutrophils in BAL fluid were evaluated by cytospin preparations. RESULTS: (1) Azithromycin pretreatment significantly inhibited both the release of three neutrophil-mobilizing cytokines (MIP-2, CXCL-5 and GM-CSF) and the accumulation of neutrophils in airways caused by mIL-17 stimulation. (2) The levels of three neutrophil-mobilizing cytokines (IL-6, MIP-2 and GM-CSF) were positively correlated with the numbers of neutrophil in BAL fluid. CONCLUSIONS: Azithromycin can inhibit neutrophil accumulation in the airways by affecting IL-17 downstream signals. This finding suggests that macrolide antibiotic application might be useful in prevention of neutrophilic pulmonary diseases characterized by high levels of IL-17.


Asunto(s)
Interleucina-17/farmacología , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Animales , Azitromicina/farmacología , Líquido del Lavado Bronquioalveolar/química , Quimiocina CXCL2/metabolismo , Quimiocinas CXC/metabolismo , Ensayo de Inmunoadsorción Enzimática , Factor Estimulante de Colonias de Granulocitos/metabolismo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Interleucina-6/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C
12.
Vaccine ; 30(21): 3223-30, 2012 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-22342709

RESUMEN

The protective effect of revaccination with Mycobacterium bovis Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis in animals is controversial. To investigate whether revaccination of neonates with BCG could improve the protection against M. tuberculosis, C57BL/6 neonates were vaccinated with BCG on day 1, or on days 1, 7, and 14, and the mice at eight weeks of age were challenged with M. tuberculosis and monitored for survival. The M. tuberculosis burden in their livers and lungs, the pathological changes in the lungs, their splenic T cell responses and serum cytokines were examined longitudinally post-challenge. BCG vaccination significantly prevented the M. tuberculosis-related mouse death and reduced the burden of M. tuberculosis in the liver and lungs, and lung damage in the mice, particularly at early stage of the pathogenic process in the BCG-revaccinated mice. However, the BCG revaccination-induced protection waned over time. BCG vaccination did not significantly modulate the levels of serum IFN-γ and the frequency of splenic PPD-reactive IFN-γ-secreting T cells, but significantly decreased the levels of serum TNF-α and PPD-specific IL-4 responses at 3 weeks post challenge. Taken together, these data suggest that revaccination of neonates with BCG elicits improved, early protection against M. tuberculosis by modulating cytokine responses in adult mice.


Asunto(s)
Vacuna BCG/administración & dosificación , Vacuna BCG/inmunología , Inmunización Secundaria/métodos , Mycobacterium tuberculosis/inmunología , Tuberculosis/prevención & control , Animales , Animales Recién Nacidos , Carga Bacteriana , Citocinas/sangre , Modelos Animales de Enfermedad , Femenino , Hígado/microbiología , Pulmón/microbiología , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Mycobacterium tuberculosis/patogenicidad , Bazo/inmunología , Análisis de Supervivencia , Linfocitos T/inmunología , Tuberculosis/mortalidad
13.
Zhonghua Jie He He Hu Xi Za Zhi ; 35(11): 843-8, 2012 Nov.
Artículo en Chino | MEDLINE | ID: mdl-23290041

RESUMEN

OBJECTIVE: To establish and evaluate the Chinese rhesus model of tuberculosis. METHODS: Twelve Chinese rhesus macaques, randomly divided into 3 groups, were inoculated with 2 different doses of Mycobacterium tuberculosis H(37) Rv strain via both bronchoscopic and intratracheal instillation into the lungs. Clinical observation and laboratory examinations were performed, including erythrocyte sedimentation rate, C-reactive protein, tuberculin skin test and X-ray examination. Histopathological assessments were performed in the 24th week postinfection. Statistical analysis was performed by ANOVA in the 3 groups. RESULTS: After infection all the animals manifested fever, weight lose, lack of appetite, coughing and other symptoms of tuberculosis. The temperature gradually increased and reached a peak [(40.1 ± 0.2)°C] at the 8th week postinfection. The weight decreased significantly at 24th week postinfection (-5.5 ± 5.6)%. Erythrocyte sedimentation rate elevated significantly at the 6th to 8th week postinfection (36 ± 40) mm/1 h. C-reactive protein was significantly increased at the 6th to 24th week after infection (75.8 ± 49.8) mg/L. The positive rate of tuberculin skin test was 100%. In Group I (bronchoscopic instillation, 20 CFU) the disease developed slowly, and the main manifestation of chest X-ray was patchy shadows. In group II (bronchoscopic instillation, 100 CFU) and group III (intratracheal instillation, 100 CFU) the disease developed rapidly, and the main manifestation of chest X-ray was patchy and nodular lesions during the 4th to the 12th week postinfection, but became large patchy and consolidation lesions during the 12th to the 24th week postinfection. Tuberculosis granuloma and caseous necrosis, similar to the pathological changes of human tuberculosis, were found in the lungs, mediastinal lymph nodes, kidney and spleen. The results of acid-fast stain were positive. The most serious pathological manifestations were observed in group II, followed by group III and group I. The highest bacterial load of the right lung was seen in group II, followed by group I and group III. CONCLUSIONS: A chinese rhesus model of tuberculosis was successfully developed via both bronchoscopic and intratracheal instillation. Their clinical manifestations, disease progression and pathological changes were similar to human primary tuberculosis and hematogenous disseminated tuberculosis.


Asunto(s)
Modelos Animales de Enfermedad , Mycobacterium tuberculosis , Tuberculosis , Animales , Carga Bacteriana , Sedimentación Sanguínea , Granuloma/microbiología , Granuloma/patología , Pulmón/microbiología , Pulmón/patología , Macaca mulatta , Prueba de Tuberculina , Tuberculosis/patología
14.
J Neuroimmune Pharmacol ; 6(3): 362-70, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20938809

RESUMEN

Mycobacterium tuberculosis is the most common communicable infectious disease worldwide and the top killer of human immunodeficiency virus (HIV)-infected people. Because of common dual HIV and M. tuberculosis infections, the emergence of multidrug-resistant M. tuberculosis strains, the lack of effective vaccination, the morbidity, and the mortality of M. tuberculosis infection are increasing sharply. Therefore, there is an urgent need for vaccine and drug development against M. tuberculosis infection. These require appropriate animal models that closely resemble human disease. To this end, we infected Chinese rhesus macaques with the M. tuberculosis H37Rv strain. Bronchoscopy was used to inoculate nine monkeys with different doses of M. tuberculosis H37Rv strain. Regardless of the M. tuberculosis dose, all monkeys were infected successfully. This was shown by clinical, laboratory, and histopathology assessments. Among nine infected monkeys, six developed acute rapid progressive tuberculosis and the remaining animals mirrored early-stage chronic disease. These data, taken together, demonstrate that Chinese rhesus macaques are highly susceptible to M. tuberculosis infection and develop similar manifestations of disease that are seen in humans. This model affords new opportunities for studies of M. tuberculosis disease pathology and therapeutics.


Asunto(s)
Modelos Animales de Enfermedad , Macaca mulatta/microbiología , Mycobacterium tuberculosis/fisiología , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patología , Tuberculosis Pulmonar/fisiopatología , Animales , Femenino , Masculino
15.
Pharmacology ; 85(6): 365-71, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20530976

RESUMEN

BACKGROUND: Due to the long duration of treatment and the emergence of multidrug-resistant strains, new antitubercular agents are urgently needed. I2906, as a novel lead, was screened and tested for efficacy in vitro and in vivo. METHODS: To determine the efficacy of I2906,the minimum inhibitory concentrations against Mycobacterium tuberculosis and cytotoxicity were tested, and its in vivo activities were assessed by administering it to mice infected with M. tuberculosis H37Rv or multidrug-resistant strain. RESULTS: Under in vitro conditions, I2906 showed excellent antimycobacterial activities and low cytotoxicity. In a murine model infected with M. tuberculosis H37Rv, the reductions on bacterial loads of both lungs and spleen were statistically significant (p < 0.05) between I2906-treated mice and untreated controls after 4 weeks. Further, the colony-forming unit counts in the lungs were dramatically lower (p < 0.05) than that of isoniazid-treated mice by the addition of I2906 after 8 weeks. Moreover, survival rate was increased by I2906 treatment. For multidrug-resistant strain infection, bacterial counts were reduced significantly in the lungs and spleen due to I2906 treatment in comparison with data from untreated controls (p < 0.05). CONCLUSIONS: I2906 displayed potential antimicrobial activities against M. tuberculosis H37Rv and drug-resistant strains in vitro and in vivo, and could improve efficacy of isoniazid in vivo.


Asunto(s)
Antituberculosos/uso terapéutico , Hidrazinas/farmacología , Hidrazinas/toxicidad , Mycobacterium tuberculosis/efectos de los fármacos , Quinolonas/farmacología , Quinolonas/toxicidad , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Pulmonar/tratamiento farmacológico , Animales , Antituberculosos/sangre , Antituberculosos/farmacología , Antituberculosos/toxicidad , Línea Celular Tumoral , Recuento de Colonia Microbiana , Evaluación Preclínica de Medicamentos , Femenino , Haplorrinos , Humanos , Hidrazinas/sangre , Isoniazida/farmacología , Isoniazida/uso terapéutico , Pulmón/microbiología , Pulmón/patología , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/patogenicidad , Quinolonas/sangre , Bazo/microbiología , Análisis de Supervivencia , Tuberculosis Resistente a Múltiples Medicamentos/microbiología , Tuberculosis Resistente a Múltiples Medicamentos/patología , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patología
16.
J Acquir Immune Defic Syndr ; 53(3): 285-91, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20051873

RESUMEN

The increasing prevalence of HIV-1 subtype B' in China and Southeast Asia calls for efforts to develop a relevant animal model to study viral transmission and pathogenesis. Because there are significant differences between subtype B' HIV-1 and other chimeric simian/human immunodeficiency viru (SHIVs) in the env gene, a novel SHIV, designated SHIV(B'WHU), was generated by replacing counterparts of SHIV(SF33) with tat/rev/vpu/env genes derived from a primary, CCR5-tropic, subtype B' HIV-1 strain of a Chinese patient. SHIV(B'WHU) was able to replicate in rhesus peripheral blood mononuclear cells and used CCR5 as its major coreceptor. Moreover, after serial passages in Chinese macaques, the in vivo infectivity of SHIV(B'WHU) was enhanced, yet no significant sequence changes were found in viral envelopes, and the virus did not change its CCR5-tropism. CD4(+) T-cell loss, however, was found in the intraepithelial lymphocytes of small intestines of infected macaques. Our findings have implications in understanding the early pathogenesis of SHIV(B'WHU) in Chinese macaques.


Asunto(s)
Modelos Animales de Enfermedad , VIH-1/genética , Receptores CCR5/fisiología , Receptores Virales/fisiología , Síndrome de Inmunodeficiencia Adquirida del Simio/virología , Virus de la Inmunodeficiencia de los Simios/genética , Virus de la Inmunodeficiencia de los Simios/patogenicidad , Animales , Asia Sudoriental , Linfocitos T CD4-Positivos/inmunología , China , Ingeniería Genética , Humanos , Intestino Delgado/inmunología , Macaca , Recombinación Genética , Tropismo Viral , Virulencia
17.
Vaccine ; 27(44): 6179-85, 2009 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-19712772

RESUMEN

Tuberculosis (TB) remains a major infectious disease worldwide despite chemotherapy and BCG vaccine. The efficacy of the current TB vaccine BCG varies from 0 to 80%. New vaccines that have better protection than BCG or have the capability to boost BCG-primed immunity are urgently needed. We have previously constructed a fusion protein Ag85B-MPT64(190-198)-Mtb8.4 (AMM). In this study, we investigated the immunogenicity of the fusion protein AMM in a novel adjuvant of dimethyl-dioctyldecyl ammonium bromide and BCG polysaccharide nucleic acid (DDA-BCG PSN), and its capacity to boost BCG-primed immunity. The anti-Ag85B antibodies IgG1 and IgG2a were determined using ELISA and the number of spleen cells secreting IFN-gamma was determined by ELISPOT. In addition, the ability of the subunit vaccine AMM to boost BCG-primed immunity against Mycobacterium tuberculosis was analyzed. The fusion protein AMM induced more effective humoral and cell-mediated immune responses in mice than Ag85B alone. Mice primed with BCG vaccination followed by boosting with AMM produced a stronger immune response and afforded a better protection against M. tuberculosis infection than mice immunized with BCG alone or BCG priming followed by boosting with Ag85B. These findings suggest that AMM is a promising candidate subunit vaccine to enhance the protective efficiency of BCG.


Asunto(s)
Aciltransferasas/inmunología , Antígenos Bacterianos/inmunología , Vacuna BCG/inmunología , Proteínas Bacterianas/inmunología , Proteínas Recombinantes de Fusión/inmunología , Tuberculosis/prevención & control , Adyuvantes Inmunológicos , Animales , Anticuerpos Antibacterianos/sangre , Femenino , Inmunidad Celular , Inmunidad Humoral , Inmunoglobulina G/sangre , Interferón gamma , Ratones , Ratones Endogámicos C57BL , Mycobacterium tuberculosis/inmunología , Tuberculosis/inmunología , Vacunas de Subunidad/inmunología
18.
Zhonghua Jie He He Hu Xi Za Zhi ; 32(9): 685-8, 2009 Sep.
Artículo en Chino | MEDLINE | ID: mdl-20079283

RESUMEN

OBJECTIVE: To investigate the effects of inactivation of CD(4)(+)CD(25)(+) regulatory T cells (Treg) combined with the administration of levofloxacin (LFX) on the cellular immune response of murine tuberculosis. METHODS: Inactivation of Treg was achieved by intraperitoneal injection of anti-CD(25), clone PC61. Female C57BL/6 mice were divided into 4 groups, PC61 alone, LFX alone, PC61 plus LFX, and the control, with 19 mice in each group. The LFX group and the control group were treated with rat-IgG isotope control. Mice were inoculated with H(37) Rv (1 x 10(6) CFU) via the tail vein 3 days later. From the 2nd day, the LFX group and the PC61 plus LFX group received intragastric administration of LFX at 200 mg x kg(-1) x d(-1) per mouse for 45 days. Blood and spleen Tregs were measured by flow cytometry. The cellular immune response and pulmonary histopathology at different time points were also evaluated after infection. RESULTS: At the 10th and 30th day, the ratio of CD(4)(+)CD(25)(+)/CD(4)(+)T cells in the spleen was (30 +/- 4)% and (17.3 +/- 1.6)% respectively in the control group, (21 +/- 4)% and (16.1 +/- 1.3)% respectively in the PC61 group, (44 +/- 6)% and (24.7 +/- 2.0)% respectively in the LFX group, (24 +/- 3)% and (10.4 +/- 1.0)% respectively in the PC61 plus LFX group. The differences were significant between groups (q = 3.62 - 5.56, P < 0.05), but the difference between the PC61 plus LFX group and the PC61 group at the 10th day. Same results were obtained from the peripheral blood. PC61 plus LFX therapy resulted in BCG specific cytokine response (IL-17, IFN-gamma, TNF-alpha) from murine spleen cells at the 10th and the 30th day, and also in milder pathologic changes and the lowest mortality. CONCLUSIONS: The cellular immune response was enhanced by Treg inactivation and LFX therapy, which decreased the pathologic changes and the mortality of murine tuberculosis.


Asunto(s)
Antibacterianos/uso terapéutico , Levofloxacino , Ofloxacino/uso terapéutico , Linfocitos T Reguladores/inmunología , Tuberculosis Pulmonar/tratamiento farmacológico , Animales , Femenino , Ratones , Ratones Endogámicos C57BL , Tuberculosis Pulmonar/inmunología
19.
Vaccine ; 23(24): 3202-9, 2005 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-15837221

RESUMEN

An inactivated vaccine for severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) was evaluated in rhesus monkeys. The monkeys were inoculated intramuscularly (i.m.) with 0.5, 5, 50, or 5000 microg of vaccine, or PBS as control, and boosted on day 7. After 3 weeks, they were challenged with the NS-1 strain of SARS-CoV. The humoral and mucosal immune responses, clinical signs, chemical indices and viremia were monitored following the immunization and challenge. The control animals who received PBS developed atypical SAR-CoV infection after viral challenge, according to clinical, virological and pathological findings. No systematic side effects were observed in vaccinated animals post-immunization, even in at the high dose of 5000 microg. The 50 microg dosage of vaccine elicited SARS-CoV specific immune responses against viral infection as compared to the partial immunity elicited by 0.5 and 5 microg doses. The results show that this inactivated vaccine can induce effective concomitant humoral and mucosal immunity against SARS-CoV infection, is safe in monkeys, and the vaccine maybe a good candidate for clinical trials.


Asunto(s)
Síndrome Respiratorio Agudo Grave/inmunología , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/inmunología , Vacunas Virales/inmunología , Animales , Citocinas/biosíntesis , Ensayo de Inmunoadsorción Enzimática , Femenino , Inmunidad Mucosa/inmunología , Inmunoglobulina A/análisis , Inmunoglobulina A/biosíntesis , Inmunoglobulina G/análisis , Inmunoglobulina G/biosíntesis , Macaca mulatta , Masculino , Pruebas de Neutralización , Radiografía Torácica , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Síndrome Respiratorio Agudo Grave/diagnóstico por imagen , Síndrome Respiratorio Agudo Grave/virología , Vacunas de Productos Inactivados/efectos adversos , Vacunas de Productos Inactivados/inmunología , Vacunas Virales/efectos adversos
20.
Zhonghua Bing Li Xue Za Zhi ; 33(3): 242-6, 2004 Jun.
Artículo en Chino | MEDLINE | ID: mdl-15256117

RESUMEN

OBJECTIVE: To investigate the transcription level and protein expression of HIF-1alpha and VEGF in SW480 cell line and colorectal adenocarcinoma, and to determine whether HIF-1alpha plays a role in angiogenesis through its regulation of VEGF. METHODS: HIF-1alpha mRNA expression was analyzed by in situ hybridization. HIF-1alpha and VEGF protein expressions were determined by immunochemical streptavidin/peroxidase (SP) in SW480 cells and colorectal carcinoma tissue samples and Western blot, using proteins extracted from SW480 cells. Tumor tissue microvessel density (MVD) was determined by CD34 immunostaining of colorectal carcinomas. RESULTS: The levels of HIF-1alpha mRNA changed significantly in response to different oxygen concentrations and an addition of genistein in SW480 cells. Immunocytochemistry revealed that the levels of HIF-1alpha, VEGF protein expression in SW480 cells were significantly higher under hypoxia than those in nomoxia (P < 0.01, P < 0.05 respectively). However, addition of genistein, an inhibitor of HIF-1alpha, suppressed such responses to hypoxia. Western blot analysis showed that SW480 cells exposed to hypoxia expressed a high level of HIF-1alpha protein, compared to a weak expression in nomoxia. The addition of genistein in hypoxia suppressed the over-expression of HIF-1alpha. The positive rates of HIF-1alpha mRNA by in situ hybridization in colorectal adenomas and adenocarcinomas were 38.9% (7/18) and 67.7% (42/62), respectively. The percentage of HIF-1alpha mRNA positive cells varied significantly from colorectal adenomas to adenocarcinomas at different Duke stages (P < 0.05), and HIF-1alpha mRNA was higher in adenocarcinomas than in adenomas (P < 0.01). The positive rates of HIF-1alpha and VEGF protein expression in adenocarcinomas were 43.5% (27/62) and 37.1% (23/62), respectively. The expression of VEGF elevated as the Duke tumor staging increased. The conformation rate of HIF-1alpha and VEGF was 74.2% (46/62). MVD was significantly higher in HIF-1alpha and/or VEGF positive tumors than those without (P < 0.01 and P < 0.05 respectively). Among the four groups, i.e. HIF-1alpha+/VEGF+, HIF-1alpha+/VEGF-, HIF-1alpha+/VEGF- and HIF-1alpha-/VEGF-, the difference of MVD was highly significant (P < 0.01). HIF-1alpha expression was correlated significantly with VEGF expression and microvessel density. CONCLUSIONS: These findings suggest hypoxia induces the expression of HIF-1alpha and VEGF in colorectal adenocarcinoma. HIF-1alpha may play an important role in angiogenesis and tumor progression by regulating the expression of VEGF in human colorectal carcinoma.


Asunto(s)
Adenocarcinoma/patología , Neoplasias Colorrectales/patología , Factores de Transcripción/biosíntesis , Adenocarcinoma/irrigación sanguínea , Adenocarcinoma/metabolismo , Neoplasias Colorrectales/irrigación sanguínea , Neoplasias Colorrectales/metabolismo , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia , Microcirculación/patología , Neovascularización Patológica/etiología , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Factores de Transcripción/genética , Células Tumorales Cultivadas , Factor A de Crecimiento Endotelial Vascular/biosíntesis , Factor A de Crecimiento Endotelial Vascular/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...